Orthometrix Osake

Orthometrix EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Orthometrix (OMRX) 12.8.2026 päivämäärällä on 134 467,00 USD.

EBITDA

134 467,00USD

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Orthometrix on 2026 134 467,00 USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Orthometrix oli 2025 - USD. Se laskee % matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Orthometrix Osakeanalyysi

Mitä Orthometrix tekee? Orthometrix Inc is a leading provider of medical devices and services in the field of orthopedics. The company was founded in 1986 and is headquartered in White Plains, New York. Orthometrix operates various business segments, including the development and manufacturing of medical devices, as well as the provision of services related to orthopedic conditions. Orthometrix's business model is based on the development and manufacturing of medical devices that help diagnose and treat orthopedic conditions. In addition, the company also offers services related to orthopedic conditions, such as posture and gait analysis. The different divisions of Orthometrix include diagnostics, rehabilitation, and medical devices. In the diagnostics area, Orthometrix offers a range of products that help diagnose orthopedic conditions. These include electromyography systems, which measure the electrical activity of muscles, as well as motion analysis systems that analyze posture, gait, and muscle function. In the rehabilitation area, Orthometrix offers a wide range of products that help rehabilitate the musculoskeletal system. These include weights and bands that can improve muscle training, as well as biofeedback systems that provide feedback on muscle activity. In the medical devices area, Orthometrix offers a range of devices that can be used to treat orthopedic conditions. These include knee braces that help improve knee protection, as well as hand and elbow braces that can be used to stabilize the wrist and elbow. Orthometrix has also specialized in providing services related to orthopedic conditions. This includes posture and gait analysis, which can help diagnose and treat orthopedic problems. Orthometrix also offers training and continuing education for medical professionals to ensure they are up to date with developments in the field of orthopedics. Overall, Orthometrix has achieved a leading position in the orthopedics field and is an important provider of medical devices and services for healthcare professionals and patients worldwide. With a wide range of products and services, Orthometrix has successfully established itself in the market and will continue to grow. Orthometrix on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Orthometrix osakkeesta

Yhtiön Orthometrix EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 134 467,00 USD vuonna 2026.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Orthometrix:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n USD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Orthometrix historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Orthometrix

Kaikki tunnusluvut — Orthometrix